TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:10 PM EDT
TriSalus Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$7.00
Upside
+50.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +50.54% | Mar 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +50.54% | Mar 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +158.06% | Dec 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +136.56% | Mar 28, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +136.56% | Jan 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +115.05% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +136.56% | Nov 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +136.56% | Nov 11, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $13 | Buy | Initiates | $13 | +168.82% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +115.05% | Sep 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +158.06% | Jun 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +158.06% | May 30, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +244.09% | May 10, 2024 |